STOCK TITAN

ReposiTrak SEC Filings

TRAK NYSE

Welcome to our dedicated page for ReposiTrak SEC filings (Ticker: TRAK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

This page provides access to U.S. Securities and Exchange Commission filings for ReposiTrak, Inc. (NYSE: TRAK), a Nevada corporation that operates a cloud-based food traceability, compliance and supply chain data platform. Through these filings, investors can review how the company reports its financial results, corporate actions and governance matters in accordance with SEC requirements.

ReposiTrak’s recent Form 8-K filings include disclosures about quarterly cash dividend declarations on its common stock, authorization of a 10b5-1 share repurchase program under a broader repurchase authorization, earnings releases for fiscal quarters and years, and the results of its annual meeting of stockholders. These current reports also reference attached press releases and earnings call transcripts that provide additional detail on financial performance, capital allocation and operational commentary.

In addition to current reports, ReposiTrak files periodic reports such as Form 10-K annual reports and Form 10-Q quarterly reports, which contain audited or reviewed financial statements, management’s discussion and analysis, risk factor disclosures and information on its business, including its focus on food traceability, regulatory compliance and supply chain solutions delivered through cloud-based applications.

Stock Titan’s filings page is designed to surface these documents as they are made available on EDGAR and to pair them with AI-powered summaries that explain the key points in accessible language. Users can quickly identify items such as dividend announcements, share repurchase authorizations, earnings results and shareholder meeting outcomes, and then drill into the underlying SEC reports for more detail. This same interface can also be used to monitor insider and executive transactions reported on forms such as Form 4, as those become available for ReposiTrak insiders.

Rhea-AI Summary

ReposiTrak, Inc. (TRAK) CEO, Director, and 10% owner Randall K. Fields reported a sale of common stock on 10/20/2025. The filing shows a disposition of 7,500 shares coded “S,” executed under a Rule 10b5-1 trading plan established to meet charitable commitments.

The weighted average sale price was $15.467, with individual trades ranging from $14.80 to $15.21. Following the reported transaction, the filing lists 35,000 shares indirectly held by RK Fields Charitable 2022, LLC.

Additional beneficial holdings disclosed include 3,683,955 shares (direct), 615,260 shares indirectly by Riverview Financial Corp., 30,667 shares indirectly by spouse, and 333,643 shares indirectly by Fields Management, Inc. The filing also lists Series B Preferred Stock positions: 289,673 shares indirectly by Riverview Financial Corp. and 6,721 shares indirectly by spouse.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.12%
Tags
insider
-
Rhea-AI Summary

ReposiTrak (TRAK) disclosed that CEO, director and 10% owner Randall K. Fields sold a total of 7,500 shares of common stock on October 14–15, 2025 under a Rule 10b5-1 trading plan executed through RK Fields Charitable 2022, LLC, established to help meet charitable commitments.

Transactions included: 1,500 shares at a weighted average price of $14.7377 on 10/14, 1,640 shares at $14.4227 on 10/14, and 4,360 shares at $14.4227 on 10/15. Following these sales, the filing shows 42,500 shares held indirectly by the charitable LLC and 3,683,955 shares held directly, alongside additional indirect holdings through affiliated entities.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Randall K. Fields, who serves as Chief Executive Officer, Director and a >10% owner of ReposiTrak, Inc. (TRAK), reported a sale of 7,500 shares of common stock on 10/07/2025 at a weighted average price of $14.9711 per share under a Rule 10b5-1 trading plan. The filing shows substantial remaining holdings: 3,683,955 shares held directly, 615,260 shares indirectly via Riverview Financial Corp., 333,643 via Fields Management, Inc., and other indirect holdings including 50,000 shares held by RK Fields Charitable 2022, LLC.

The sale was executed automatically to satisfy charitable commitments and occurred across multiple transactions with prices ranging from $14.16 to $15.21. No derivative securities were reported as changed in this filing.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.97%
Tags
insider
Rhea-AI Summary

Randall K. Fields, CEO, director and 10% owner of ReposiTrak, Inc. (TRAK), reported multiple sales of Common Stock under an existing Rule 10b5-1 trading plan established to meet charitable commitments. The Form 4 shows five reported dispositions executed on 09/29/2025, 09/30/2025 and 10/01/2025 totaling 7,500 shares sold at weighted-average prices ranging from approximately $14.91 to $16.97 per share. The sales were made indirectly by RK Fields Charitable 2022, LLC pursuant to the trustee role in a charitable remainder unitrust. The filing lists significant remaining holdings held directly and indirectly, including large direct and indirect positions in common stock and Series B preferred stock across related entities and spouse holdings.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.94%
Tags
insider
-
Rhea-AI Summary

ReposiTrak, Inc. filed a current report to let investors know it has released its latest financial results. On September 29, 2025, the company issued a press release and held an earnings call covering its financial performance for the fiscal quarter and year ended June 30, 2025.

The press release is included as Exhibit 99.1 and the earnings call transcript as Exhibit 99.2. The company notes that this information is being furnished rather than filed, which limits how it is treated under certain securities law liability provisions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

ReposiTrak, Inc. (TRAK) reports operational and financial disclosures in its Form 10-K. The company states it has not identified any cybersecurity threats that have materially affected or are reasonably likely to materially affect its business, and it maintains employee reporting procedures and quarterly Audit Committee reviews of cybersecurity policies. Contract asset balances at June 30, 2025 include a current contract asset of $428,585. The company reports zero bank debt and a revolving credit facility balance of zero as of June 30, 2025, while maintaining cash/liquid assets above previously required covenant levels. Common stock details show 336,098 and 616,470 shares issued and outstanding at June 30, 2025 and 2024 (par $0.01), and total common shares outstanding of 18,282,805 at June 30, 2025. The company disclosed lease arrangements with no future lease commitments under a prior lease and a month-to-month office lease treated as short-term. It disclosed stock plans (2023 Plan and ESPP), warrant activity, and preferred stock designations including 700,000 Series B Preferred with dividend rates of 7% (cash) or 9% (paid-in-kind) and a redemption price of $10.70 per share. The company repurchased 2,131,384 common shares at an average of $6.20 and has $7,792,173 remaining under its repurchase program as of June 30, 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10.51%
Tags
annual report
Rhea-AI Summary

Randall K. Fields, CEO, Director and 10% owner of ReposiTrak, Inc. (TRAK), reported multiple dispositions of company stock on 09/22/2025 and 09/23/2025. The report shows sales of 3,000 shares on 09/22/2025 at a weighted average price of $17.5775 and 4,000 shares on 09/23/2025 at a weighted average price of $17.3856, executed pursuant to a Rule 10b5-1 trading plan established by the reporting person as trustee of a charitable unitrust.

The Form 4 discloses significant other holdings and dispositions: a reported disposition of 3,683,955 shares of common stock, direct ownership of 615,260 shares indirectly, and various indirect holdings through Riverview Financial Corp., spouse, Fields Management, Inc., and a charitable LLC. Footnotes state the sales occurred in multiple transactions and provide price ranges for each weighted average.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.74%
Tags
insider
-
Rhea-AI Summary

ReposiTrak, Inc. declared a quarterly cash dividend of $0.02 per share, equivalent to $0.08 annually, on its common stock. The dividend was announced on September 19, 2025, will be payable on or about November 14, 2025, and applies to holders of record as of September 30, 2025. The company attached a press release as Exhibit 99.1 to this Current Report. The filing states that the exhibit and related Item 8.01 disclosure are furnished, not filed, under the Exchange Act.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.96%
Tags
current report
-
Rhea-AI Summary

Randall K. Fields, identified as Chief Executive Officer, director and a >10% owner of ReposiTrak, Inc. (TRAK), reported a series of open-market sales of the company's common stock executed 09/15/2025–09/17/2025. The Form 4 discloses three reported sales under a Rule 10b5-1 trading plan established by Fields in his capacity as trustee of the 2022 RK Fields Charitable Remainder Unitrust to satisfy charitable commitments. The reported transactions: 3,000 shares sold on 09/15/2025 at a weighted average price of $17.0201, 1,965 shares on 09/16/2025 at $17.0026, and 2,535 shares on 09/17/2025 at $17.2325. The footnotes state the shares were sold in multiple transactions at prices ranging from $16.97 to $17.65 and that the reporting person will provide breakouts by price on request.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Randall K. Fields, reported a sale of 7,500 shares of ReposiTrak, Inc. (TRAK) common stock on 09/08/2025 under a Rule 10b5-1 trading plan. The Form 4 states a weighted average price of $16.0594 for the reported sale and a footnote discloses that the shares were sold in multiple transactions at prices ranging from $17.076 to $17.38. The filing explains the trading plan was adopted by Mr. Fields in his capacity as trustee to satisfy charitable commitments.

The filing also lists beneficial ownership stakes across several entities and relationships, including 3,683,955 shares (listed as direct), 615,260 shares indirect via Riverview Financial Corp., 30,667 shares indirect by spouse, and 79,500 shares indirect by RK Fields Charitable 2022, LLC following the reported transaction. Multiple entries show indirect holdings through Fields Management, Inc. and Riverview Financial Corp., and ownership of Series B preferred shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

How many ReposiTrak (TRAK) SEC filings are available on StockTitan?

StockTitan tracks 66 SEC filings for ReposiTrak (TRAK), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for ReposiTrak (TRAK)?

The most recent SEC filing for ReposiTrak (TRAK) was filed on October 21, 2025.